Oct 18, 2022 / 12:00PM GMT
Presentation
Oct 18, 2022 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
Roche Holding AG - Head of IR
* Severin Schwan
Roche Holding AG - CEO & Executive Director
* Thomas Schinecker
Roche Holding AG - CEO of Roche Diagnostics
* William N. Anderson
Roche Holding AG - CEO of Roche Pharmaceuticals
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emily Field
Barclays Bank PLC, Research Division - Research Analyst
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
*
Roche Holding AG
(LTS:0QOK)
CHF
263.05
-1.65 (-0.62%)
Market Cap: 211.30 Bil
Enterprise Value: 236.93 Bil
PE Ratio: 19.78
PB Ratio: 7.21
GF Score: 86/100 Q3 2022 Roche Holding AG Corporate Sales Presentation Transcript
Oct 18, 2022 / 12:00PM GMT
Release Date Price:
CHF324.8
(-1.68%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot